Founded in 2001, the company is headquartered in the beautiful Songshan Lake High-tech Park in Dongguan City.
The Group has always been committed to human health services. The industrial distribution is distributed in the four aspects of pharmaceutical production and R&D, pharmaceutical distribution and sales, medical services and healthy pensions. The total assets have reached more than 2 billion yuan and more than 2,000 employees have come out of an industry. Chain complete medical health industry road.
Jinmeiji Pharmaceuticals belongs to the production and R&D section of Jinmeiji Group, with an investment of approximately RMB 350 million and a building area of 26,000 square meters. It is a key project in Dongguan (project number J2010051). Its research interests include anti-cardiovascular drugs and anti-tumor drugs. Drugs, genetic engineering and biological drugs, etc., The main production equipment is in line with international standards, and most of them are imported equipment. In 2016, it had passed the Chinese GMP certification of hard capsules and tablets. Currently, it is actively preparing to meet the EU GMP certification.
The company is committed to becoming a high-tech pharmaceutical company that meets international GMP standards, has independent R&D and innovation capabilities, establishes global partnerships, and enters the international market.